Cocoon Biotech
BioTech/Drugs - Cambridge, MA, US
Cocoon Biotech Senior Management
Cocoon Biotech Details
Cocoon Biotech, Inc., was founded in 2013 to bring the freedom of living a healthy productive life to patients worldwide. Cocoon Biotech is developing a drug-delivery platform based on formulations of fibroin, a protein derived from the cocoon of the silkworm (Bombyx mori). Recent advances in our understanding of fibroin biochemistry has allowed expansion of the versatility of the material into alternate physical formats such as hydrogels and implants loaded with active drug substances. Cocoon is leveraging silk fibroin as a novel biomaterial for the stability and delivery of therapeutics across human health and animal health. Cocoon's first products are silk fibroin formulated with small molecules that target pain and inflammation in ophthalmology and osteoarthritis indications.
Cocoon Biotech Technologies
E-commerce Platforms
Squarespace ECommerce
Email Providers
Gmail
Domain Name Services
NSOne
Other
Mobile Friendly